Your browser doesn't support javascript.
loading
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study.
Gossec, Laure; Siebert, Stefan; Bergmans, Paul; de Vlam, Kurt; Gremese, Elisa; Joven-Ibáñez, Beatríz; Korotaeva, Tatiana V; Lavie, Frederic; Noël, Wim; Nurmohamed, Michael T; Sfikakis, Petros P; Theander, Elke; Smolen, Josef S.
Afiliação
  • Gossec L; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France laure.gossec@aphp.fr.
  • Siebert S; Rheumatology Department, AP-HP, University Hospital Pitié Salpêtrière, Paris, France.
  • Bergmans P; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Glasgow, UK.
  • de Vlam K; Biostatistics, Janssen-Cilag BV, Breda, The Netherlands.
  • Gremese E; Department of Rheumatology, Universitair Ziekenhuis Leuven, Leuven, Flanders, Belgium.
  • Joven-Ibáñez B; Division of Rheumatology, Fondazione Policlinico Agostino Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Korotaeva TV; Rheumatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Lavie F; Department of Spondyloarthritis and Psoriatic Arthritis, VA Nasonova Research Institute of Rheumatology, Moscow, Russian Federation.
  • Noël W; Medical Affairs, The Janssen Pharmaceutical Companies of Johnson & Johnson, Paris, France.
  • Nurmohamed MT; Medical Affairs, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Sfikakis PP; Department of Rheumatology, Reade and VU University Medical Center, Amsterdam, The Netherlands.
  • Theander E; 1st Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece.
  • Smolen JS; Medical Affairs, Janssen, Solna, Sweden.
Ann Rheum Dis ; 81(6): 823-830, 2022 06.
Article em En | MEDLINE | ID: mdl-35210262

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Antirreumáticos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Antirreumáticos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido